Oxazolidinone represents a class of synthetic antibacterial agents used primarily to treat serious infections caused by gram-positive bacteria, including resistant strains of staphylococci, streptococci,… Read more

![Chemical structure of (4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d3](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1329641-35-1-4S-3-2R-2-2R-2-24-Difluorophenyloxiranyl-1-oxopropyl-4-benzyl-2-oxazolidinone-d3.png&w=3840&q=75)


![Chemical structure of 3-(tert-Butyl-d9)-5-[7-(bromoethyl)-2-benzofuranyl]-2-oxazolidinone
(Mixture of Diastereomers)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1185084-36-9-3-tert-Butyl-d9-5-7-bromoethyl-2-benzofuranyl-2-oxazolidinone-Mixture-of-Diastereomers.png&w=3840&q=75)
![Chemical structure of 3-(tert-Butyl-d9)-5-[7-(hydroxyethyl)-2-benzofuranyl]-2-oxazolidinone (Mixture of Diastereomers)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1189998-94-4-3-tert-Butyl-d9-5-7-hydroxyethyl-2-benzofuranyl-2-oxazolidinone-Mixture-of-Diastereomers.png&w=3840&q=75)



Oxazolidinone represents a class of synthetic antibacterial agents used primarily to treat serious infections caused by gram-positive bacteria, including resistant strains of staphylococci, streptococci, and pneumococci. As heterocyclic compounds characterized by a five-membered ring containing both nitrogen and oxygen, these drugs are critical in modern therapeutic regimens. To support rigorous pharmaceutical analysis, this category provides a comprehensive collection of reference standards, including the active pharmaceutical ingredient, related synthesis impurities, metabolites, and stable isotope-labelled compounds. These high-quality standards are essential for laboratories performing impurity profiling, method validation, and routine quality control. By utilizing these labelled internal standards and analytical reference materials, researchers can ensure accurate identification and quantification, supporting the stringent regulatory requirements necessary for maintaining consistent drug safety and efficacy throughout the development and manufacturing lifecycle.